Ultragenyx Pharmaceutical reported $2.58B in Market Capitalization this December of 2022, considering the latest stock price and the number of outstanding shares.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Acadia Pharmaceuticals ACAD:US USD 2.65B 373M
Agios Pharmaceuticals AGIO:US USD 1.55B 335M
Alnylam Pharmaceuticals ALNY:US USD 24.62B 6.97B
Aptinyx Inc APTX:US USD 25M 13M
Biocryst Pharmaceuticals BCRX:US USD 2.34B 376M
Biomarin Pharmaceutical BMRN:US USD 15.72B 392M
Bluebird Bio BLUE:US USD 488M 192M
Esperion Therapeutics ESPR:US USD 446M 45M
Insmed INSM:US USD 2.62B 258M
Karyopharm Therapeutics KPTI:US USD 442M 82M
Kyowa Hakko Kirin 4151:JP JPY 1.79T 143.1B
Macrogenics MGNX:US USD 213M 32M
Mirati Therapeutics MRTX:US USD 3.88B 156M
Moderna Inc MRNA:US USD 46.26B 10.56B
Neurocrine Biosciences NBIX:US USD 10.16B 841M
Ptc Therapeutics PTCT:US USD 3.61B 742M
Puma Biotechnology PBYI:US USD 108M 20M
Regeneron Pharmaceuticals REGN:US USD 75.09B 10.16B
Sarepta Therapeutics SRPT:US USD 9.68B 3.12B
Ultragenyx Pharmaceutical RARE:US USD 2.9B 1.27B
Vertex Pharmaceuticals VRTX:US USD 74.3B 2.16B
Vital Therapies VTL:US USD 97M 21M
Xoma XOMA:US USD 205M 50M